Guidelines of care for the management of acne vulgaris.

Autor: Reynolds RV; Department of Dermatology, Beth Israel Deaconess Medical Center, Boston, Massachusetts., Yeung H; Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia., Cheng CE; Division of Dermatology, Department of Medicine, University of California Los Angeles, Los Angeles, California., Cook-Bolden F; Department of Dermatology, Weill Cornell Medicine, New York, New York., Desai SR; Innovative Dermatology, Plano, Texas; Department of Dermatology, University of Texas Southwestern Medical Center, Dallas, Texas., Druby KM; Penn State Health Hampden Medical Center, Enola, Pennsylvania., Freeman EE; Department of Dermatology, Massachusetts General Hospital, Boston, Massachusetts., Keri JE; University of Miami, Miller School of Medicine, Miami, Florida; Miami VA Medical Center, Miami, Florida., Stein Gold LF; Department of Dermatology, Henry Ford Health, Detroit, Michigan., Tan JKL; Western University, London, Ontario, Canada; Windsor Clinical Research Inc., Windsor, Ontario, Canada., Tollefson MM; Departments of Dermatology and Pediatrics, Mayo Clinic, Rochester, Minnesota., Weiss JS; Department of Dermatology, Emory University School of Medicine, Atlanta, Georgia; Georgia Dermatology Partners, Snellville, Georgia., Wu PA; Department of Dermatology, University of California Davis, Sacramento, California., Zaenglein AL; Departments of Dermatology and Pediatrics, Penn State/Hershey Medical Center, Hershey, Pennsylvania., Han JM; American Academy of Dermatology, Rosemont, Illinois. Electronic address: jminhan@aad.org., Barbieri JS; Department of Dermatology, Brigham and Women's Hospital, Boston, Massachusetts.

Publikováno v: Journal of the American Academy of Dermatology [J Am Acad Dermatol] 2024 May; Vol. 90 (5), pp. 1006.e1-1006.e30. Date of Electronic Publication: 2024 Jan 30.

Beliefs and perceptions of patients with acne: Tan JKL, Vasey K, Fung KY. J Am Acad Dermatol. 2001;44:439–445

Publikováno v: In Clinical Cornerstone 2001 4(1):45-45

Use of an alternative method to evaluate erythema severity in a clinical trial: difference in vehicle response with evaluation of baseline and postdose photographs for effect of oxymetazoline cream 1·0% for persistent erythema of rosacea in a phase IV study

Autor: Eichenfield, LF, Del Rosso, JQ, Tan, JKL, Hebert, AA, Webster, GF, Harper, J, Baldwin, HE, Kircik, LH, Stein-Gold, L, Kaoukhov, A, Alvandi, N

Publikováno v: The British journal of dermatology, vol 180, iss 5

BackgroundOnce-daily topical oxymetazoline cream 1·0% significantly reduced persistent facial erythema of rosacea in trials requiring live, static patient assessments.ObjectivesTo evaluate critically the methodology of clinical trials that require l

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=od_______325::9e1e8399107d9fb4c9d015293d4e5036
https://escholarship.org/uc/item/73f0m5r5

IGAxBSA composite for assessing disease severity and response in patients with atopic dermatitis.

Autor: Paller AS; Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, IL, USA., Tan JKL; Windsor Clinical Research, Windsor, ON, Canada., Bagel J; Eczema Center of New Jersey, East Windsor, NJ, USA., Rossi AB; Sanofi Genzyme, Cambridge, MA, USA., Shumel B; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Zhang H; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA., Abramova A; Regeneron Pharmaceuticals, Inc., Tarrytown, NY, USA.

Publikováno v: The British journal of dermatology [Br J Dermatol] 2022 Mar; Vol. 186 (3), pp. 496-507. Date of Electronic Publication: 2022 Feb 25.

International Dermatology Outcome Measures (IDEOM): Report from the 2020 Annual Meeting.

Autor: Kohn AH; Charles E. Schmidt College of Medicine, Florida Atlantic University, Boca Raton, Florida, USA., Alavi A; Division of Dermatology, University of Toronto, Toronto, Ontario, Canada.; Department of Dermatology, Mayo Clinic, Rochester, Minnesota, USA., Armstrong AW; Department of Dermatology, Keck School of Medicine, University of Southern California, Los Angeles, California, USA, armstrongpublication@gmail.com., Babalola F; Joe R. & Teresa Lozano Long School of Medicine, University of Texas Health Science Center at San Antonio, San Antonio, Texas, USA., Garg A; Department of Dermatology, Donald and Barbara Zucker School of Medicine at Hofstra/Northwell, New Hyde Park, New York, USA., Gottlieb AB; Department of Dermatology, Icahn School of Medicine at Mt Sinai, New York, New York, USA., Grilli L; Patient Research Partner, International Dermatology Outcome Measures (IDEOM), Cohasset, Massachusetts, USA., Jemec GBE; Department of Dermatology, Zealand University Hospital, Roskilde, Denmark., Latella J; Patient Research Partner, International Dermatology Outcome Measures (IDEOM), Windsor, Connecticut, USA., Marcus K; Division of Dermatology and Dental Products, Office of New Drugs, US Food and Drug Administration, Silver Spring, Maryland, USA., Merola JF; Department of Dermatology and Medicine, Division of Rheumatology, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts, USA., Ortega-Loayza AG; Department of Dermatology, Oregon Health and Science University, Portland, Oregon, USA., Siegel DM; Department of Dermatology, SUNY Downstate Medical Center, Brooklyn, New York, USA., Strand V; Division of Immunology and Rheumatology, Stanford University School of Medicine, Palo Alto, California, USA., Tan JKL; Faculty of Medicine, Western University, London, Ontario, Canada., Perez-Chada LM; Department of Dermatology, Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts, USA.

Publikováno v: Dermatology (Basel, Switzerland) [Dermatology] 2022; Vol. 238 (3), pp. 430-437. Date of Electronic Publication: 2021 Sep 17.